Remdesivir for the Treatment of COVID-19: A Need for Combined and Studies to Evaluate the Efficacy.
作者信息
Naveed Muhammad, Uddin Shahab, Khan Muhammad Khalid, Khan Zakir
机构信息
Department of Pharmacology and Pharmacotherapy, 37443Faculty of Medicine, University of Szeged, Szeged, Hungary.
Department of Microbiology, School of Life Sciences, 12426Lanzhou University, Lanzhou, China.
出版信息
J Pharm Pract. 2021 Jun;34(3):343-346. doi: 10.1177/0897190021997001. Epub 2021 Feb 24.
PMID:33622090
Abstract
摘要
相似文献
1
Remdesivir for the Treatment of COVID-19: A Need for Combined and Studies to Evaluate the Efficacy.
J Pharm Pract. 2021 Jun;34(3):343-346. doi: 10.1177/0897190021997001. Epub 2021 Feb 24.
2
COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.
Med Lett Drugs Ther. 2022 Feb 21;64(1644):31-32.
3
Remdesivir for patients with COVID-19.
CMAJ. 2021 Jan 25;193(4):E125. doi: 10.1503/cmaj.202505. Epub 2021 Jan 6.
4
Remdesivir: a pendulum in a pandemic.
BMJ. 2020 Nov 24;371:m4560. doi: 10.1136/bmj.m4560.
5
Remdesivir as a broad-spectrum antiviral drug against COVID-19.
Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):541-548. doi: 10.26355/eurrev_202101_24426.
6
Efficacy of Remdesivir for COVID-19.
Discov Med. 2021 Mar-Apr;31(163):57-60.
7
Update Alert 2: Remdesivir for Adults With COVID-19.
Ann Intern Med. 2021 Dec;174(12):W114-W115. doi: 10.7326/L21-0600. Epub 2021 Oct 5.
8
Remdesivir (Veklury) for the Treatment of COVID-19 in Hospitalized Patients.
Am Fam Physician. 2021 Sep 1;104(3):311-312.
9
Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
Ann Intern Med. 2021 May;174(5):673-679. doi: 10.7326/M20-8101. Epub 2021 Feb 9.
10
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.
引用本文的文献
1
A Comprehensive Survey on the Expediated Anti-COVID-19 Options Enabled by Metal Complexes-Tasks and Trials.
Molecules. 2023 Apr 10;28(8):3354. doi: 10.3390/molecules28083354.
2
Comparative evaluation of authorized drugs for treating Covid-19 patients.
Health Sci Rep. 2022 Jun 13;5(4):e671. doi: 10.1002/hsr2.671. eCollection 2022 Jul.
3
Metal-based complexes against SARS-CoV-2.
Biometals. 2022 Aug;35(4):639-652. doi: 10.1007/s10534-022-00386-5. Epub 2022 Mar 24.
Zotero 插件